<DOC>
	<DOCNO>NCT02946853</DOCNO>
	<brief_summary>Cardiac resynchronization therapy ( CRT ) demonstrably effective device intervention patient heart failure reduce ejection fraction specific indication . However , many patient heart failure ( HF ) unable maintain sinus rhythm approximately 30-36 % CRT patient atrial fibrillation ( AF ) .</brief_summary>
	<brief_title>Junctional AV Ablation CRT-D : JAVA-CRT</brief_title>
	<detailed_description>This study design evaluate patient AF indicate CRT significant reduction leave ventricular end-systolic volume randomize atrioventricular junction ( AVJ ) ablation . In study , subject randomize receive CRT-D CRT-D AVJ ablation . Randomization stratify enrol center ( 1:1 ratio ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>Optimal pharmacologic therapy define publish guideline American Heart Association American College Cardiology Initial implantation CRTD Ischemic nonischemic cardiomyopathy LVEF ≤ 35 % NYHA class IIIV ( ambulatory ) QRS ≥ 120 m LBBB ≥ 150 m nonLBBB patient Continuous AF &gt; 6 month effort restore sinus rhythm feasible pursue Ventricular rate &gt; 110 bpm rest despite maximal medical therapy Ventricular rate &lt; 50 bpm rest Heart block/symptomatic bradycardia necessitates permanent pace Acute coronary syndrome coronary artery bypass surgery within 12 week Severe aortic mitral valvular heart disease Prior surgical percutaneous AF ablation procedure Prior AVJ ablation Any medical condition likely limit survival &lt; 1 year Patients ACC/AHA Stage D refractory Class IV symptom list transplant require inotropic support Contraindication systematic anticoagulation Renal failure require dialysis AF due reversible cause e.g . hyperthyroid state Pregnancy Participation clinical trial affect objective study History noncompliance medical therapy Inability unwillingness provide inform consent Patients shortlived AF sinus rhythm ineligible</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>CRT</keyword>
	<keyword>AV Junction Ablation</keyword>
	<keyword>LVESV</keyword>
</DOC>